Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc V.VER.H

Alternate Symbol(s):  VRSEF

Verisante Technology, Inc. is a Canada-based company. The Company does not operate any active business other than to identify and complete a reverse takeover (RTO) with a company in one of its target sectors that demonstrates significant growth potential and/or value creation opportunities for shareholders. The Company may pursue a target in any industry, it intends to focus its search on companies that meet its acquisition target characteristics within the life sciences sectors.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by Kantenahon Jan 08, 2008 6:50pm
366 Views
Post# 14171203

RE: Patience is required.

RE: Patience is required.Hello Hoboman1 - welcome to the Allen-Vanguard bullboard.

Here is a brief summary of some of the relevant facts as I see them.  The first and most obvious place to look is the company's most recent financial results (FY 2007 ended Sept. 30/07) .  A few highlights:

- Q4 revenue was $50.0 million, with EBITDA of $8.4 million (net of a one time inventory charge of $1.2 million), up from revenue of $20.0 million and EBITDA of $2.9 million in Q4 of FY 06.

- Revenue and EBITDA for FY 07 was $96.2 million and $10.0 million, respectively, up from $56.8 million and $4.3 million, respectively, in FY 06.

- VRS entered fiscal 2008 with a backlog of $135 million (more than enough to beat FY 2007's revenue numbers) 

- The company continues to generate healthy cash flow (cash at end of FY 2007 was $20.4M vs. $5.7M at end of FY 2006).

-  Gross Margin remains strong - in the 40% range.

- acquisition of Med-Eng at the end on FY 2007 is a good fit for VRS and represents opportunity to leverage growth for FY 2008 and beyond.

- IED's remain the number one threat for NATO troops in Iraq and Afghanistan.  VRS is a leader in counter-IED measures.

If you are so inclined, you may also want to refer to analyst coverage such as Versant, although I am always leery of such sources as they often have a vested interest in the performance of the stock.
https://www.grandich.com/reports/versant.01.07.08.pdf" target=_blank>https://www.grandich.com/reports/versant.01.07.08.pdf

Having said all of this, I am still of the opinion that VRS will continue to suffer, in the short-term, given the negative sentiment that dominates the market.  Therefore, delaying your purchase by a couple of months may prove to be a very wise & lucrative decision.

In the spirit of open and well-rounded debate, I invite all participants on this bullboard (particularly saniyya and MestQalander) to provide us with facts to support a more negative long-term view of this stock.  I am always open to new information and fact-based opinion.

I hope this helps Hoboman1 - Happy Investing!
 
Bullboard Posts